Lionco Pharm Grp Co Ltd Strategic Asset Allocation Index
Lionco Pharm Grp Co Ltd strategic asset allocation index. Lionco Pharm Grp Co Ltd (603669) has a Strategic Asset Allocation Index of 47.2% as of September 2023. Strategic assets (PP&E of CN¥488.34 Million plus long-term investments of CN¥-) total CN¥488.34 Million, measured against net assets of CN¥1.03 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Lionco Pharm Grp Co Ltd (603669) tangible equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Lionco Pharm Grp Co Ltd (2014–2022)
Strategic asset allocation index of Lionco Pharm Grp Co Ltd from 2014 to 2022. This chart shows how Lionco Pharm Grp Co Ltd's Strategic Asset Allocation Index has evolved across 9 annual periods from 2014 to 2022. As of September 2023, the index stands at 47.2%, representing strategic assets of CN¥488.34 Million against net assets of CN¥1.03 Billion CNY.
Lionco Pharm Grp Co Ltd Strategic Asset Allocation Index by Year (2014–2022)
Lionco Pharm Grp Co Ltd strategic asset allocation index by year from 2014 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Lionco Pharm Grp Co Ltd from 2014 to 2022, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Lionco Pharm Grp Co Ltd market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 43.7% | CN¥496.32 Million | CN¥496.32 Million | CN¥- | CN¥1.14 Billion | ▲ +10.5 pp |
| 2021 | 33.2% | CN¥484.53 Million | CN¥484.53 Million | CN¥- | CN¥1.46 Billion | ▲ +1.8 pp |
| 2020 | 31.5% | CN¥465.47 Million | CN¥465.47 Million | CN¥- | CN¥1.48 Billion | ▼ -5.9 pp |
| 2019 | 37.3% | CN¥490.52 Million | CN¥490.52 Million | CN¥- | CN¥1.31 Billion | ▼ -5.0 pp |
| 2018 | 42.3% | CN¥583.05 Million | CN¥490.82 Million | CN¥92.22 Million | CN¥1.38 Billion | ▲ +11.1 pp |
| 2017 | 31.2% | CN¥405.40 Million | CN¥405.40 Million | CN¥- | CN¥1.30 Billion | ▲ +2.7 pp |
| 2016 | 28.5% | CN¥333.06 Million | CN¥333.06 Million | CN¥- | CN¥1.17 Billion | ▼ -1.0 pp |
| 2015 | 29.5% | CN¥329.77 Million | CN¥329.77 Million | CN¥- | CN¥1.12 Billion | ▼ -52.4 pp |
| 2014 | 81.8% | CN¥306.12 Million | CN¥306.12 Million | CN¥- | CN¥374.13 Million | — |